Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ming-yi Hu"'
Autor:
Said Laribi, Phillip D. Levy, W. Frank Peacock, Abhinav Chandra, Guillaume Der Sahakian, Alex Mebazaa, Lala Dunbar, Douglas M. Char, Hector O. Ventura, Ming Yi Hu, Li Ding, P. Jourdain, Sean P. Collins, Patrick Ray, Gregg C. Fonarow, Christian Mueller, Adam J. Singer, Norman Garrison, Mason Weiss, Martin Möckel, Gregory J. Fermann
Publikováno v:
Scopus-Elsevier
Background Rapid blood pressure (BP) control improves dyspnea in hypertensive acute heart failure (AHF). Although effective antihypertensives, calcium-channel blockers are poorly studied in AHF. Clevidipine is a rapidly acting, arterial selective int
Autor:
Marilyn Stolar, Greg Williams, K. Jack Ishak, Piedad Alvarez, Ming-yi Hu, Tracy Aber Crothers, Yamei Wang, Denis Getsios
Publikováno v:
Expert Opinion on Pharmacotherapy. 14:1285-1293
Perioperative hypertension affects 80% of cardiac surgery patients and is associated with an increased risk of complications.To determine the relationship between perioperative blood pressure (BP) control and hospital costs for cardiac surgery in the
Autor:
Ming Yi Hu, Christos Lazaridis, Sergio D. Bergese, Gregory C. Williams, Gwendolyn F Lynch, Marc Lapointe, Kiwon Lee, Carmelo Graffagnino, James Love, Dietmar Schneider
Publikováno v:
Cerebrovascular diseases (Basel, Switzerland). 36(3)
Background: Intracerebral hemorrhage (ICH) causes 10-15% of primary strokes, with mortality related to hematoma volume. Blood pressure (BP) reduction may attenuate hematoma expansion. ACCELERATE (the Evaluation of Patients with Acute Hypertension and
Autor:
Steven F. Komjathy, Gregory C. Williams, William B. Smith, Diane R. Mould, Mark S. Sumeray, Ming-yi Hu, Thomas Marbury
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Clevidipine is a rapidly-acting intravenous dihydropyridine antihypertensive acting via calcium channel blockade. This was a randomized, single-blind, parallel-design study of a 72-h continuous clevidipine infusion. Method Doses of 2, 4, 8, o